Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results

QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH) ("Delcath†or the "Company†), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced preliminary financial results and business updates for the fourth quarter and year-ended December 31, 2025. Preliminary Fourth Quarter and Full-Year 2025 Financial Results (unaudited) Final financial results for the fourth quarter and full year 2025 and a detailed business update will ...